The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Post-registration experience of nivolumab (nivo) therapy in patients with advanced hepatocellular carcinoma (HCC): An international study.
 
Petros Fessas
No Relationships to Disclose
 
Ahmed Omar Kaseb
Stock and Other Ownership Interests - Gilead Sciences
Honoraria - Bayer Health; Bristol-Myers Squibb; Exelixis; Merck
Consulting or Advisory Role - Bayer Health; Bristol-Myers Squibb; Exelixis; Merck
Research Funding - Adaptimmune (Inst); Bayer/Onyx (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Hengrui Pharmaceutical (Inst); Hengrui Pharmaceutical (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Bayer/Onyx; Bristol-Myers Squibb; Exelixis; Merck
 
Yinghong Wang
Consulting or Advisory Role - Tillotts Pharma
 
Anwaar Saeed
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Exelixis
Research Funding - Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Exelixis (Inst); Five Prime Therapeutics (Inst); Merck Sharp & Dohme (Inst); Seagen (Inst)
 
David Szafron
No Relationships to Disclose
 
Tomi Jun
No Relationships to Disclose
 
Sirish Dharmapuri
No Relationships to Disclose
 
Abdul Rafeh Naqash
No Relationships to Disclose
 
Uqba Khan
Honoraria - Cardinal Health
Travel, Accommodations, Expenses - Cardinal Health; Conquer Cancer Foundation
 
Bo Yu
No Relationships to Disclose
 
Sonal D Paul
No Relationships to Disclose
 
Neil satish Nimkar
No Relationships to Disclose
 
Dominik Bettinger
No Relationships to Disclose
 
Hannah Hildebrand
No Relationships to Disclose
 
Yehia I. Mohamed
No Relationships to Disclose
 
Yi-Hsiang Huang
No Relationships to Disclose
 
Lorenza Rimassa
Honoraria - Abbvie; Amgen; AstraZeneca; Eisai; Gilead Sciences; Ipsen; Lilly; Roche; Sanofi
Consulting or Advisory Role - Amgen; ArQule; Basilea; Baxter; Bayer; Celgene; Eisai; Exelixis; Hengrui Therapeutics; Incyte; Ipsen; Italfarmaco; Lilly; Merck Sharp & Dohme; Roche; Sanofi; Sirtex Medical
Research Funding - Agios (Inst); ARMO BioSciences (Inst); ArQule (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); BeiGene (Inst); Eisai (Inst); Exelixis (Inst); Exelixis/Ipsen (Inst); Incyte (Inst); Ipsen (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - ArQule; Ipsen
 
Celina Ang
No Relationships to Disclose
 
Thomas Urban Marron
Consulting or Advisory Role - Atara Biotherapeutics; Boehringer Ingelheim; Genentech; Regeneron
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Atara Biotherapeutics (Inst); Genentech
 
David James Pinato
Consulting or Advisory Role - Eisai; Mina Therapeutics; Roche
Speakers' Bureau - Bayer; Falk Pharma; Roche; ViiV Healthcare
Research Funding - Bristol-Myers Squibb; MSD Oncology
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb